Depression and anxiety symptoms following cancer diagnosis

a cross-sectional study

Graça Cardoso, Joao Graca, Catarina Klut, Bruno Trancas, Ana Papoila

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Introduction: The aims of the present study were to assess demographic and clinical characteristics of patients after receiving a cancer diagnosis, and to determine possible risk factors for anxiety and depression. Methods: All consecutive patients aged 18 or above, were assessed before starting intravenous chemotherapy for the first time with the Hospital Anxiety and Depression Scale (HADS), the Distress Thermometer, and a Visual Analog Scale for pain. Demographic and clinical data were also collected. Results: The patients assessed (n = 270) had a mean age of 59.4 (SD = 11.8) years, and 50.7% were women. Tumours were more frequently colorectal (27.2%), lung (18.8%) and breast (17.6%), and 68.9% were stages 3 or 4. A HADS Anxiety score ≥8 was present in 30% of the patients, a Depression score ≥8 in 24.1%, and a Distress score ≥4 in 44.4%. Independent risk factors for HADS Depression score ≥8 were being a woman (OR = 2.45; p = 0.004), being older (OR = 1.04; p = 0.005), and cancer stage 3–4 (OR = 2.24; p = 0.023) in the multivariable analysis; for Anxiety ≥8 they were being a woman (OR = 2.47; p = 0.002), having a past psychiatric consultation (OR = 2.83; p = 0.029), and cancer stage 3–4 (OR = 1.90; p = 0.047). Conclusion: These results suggest the need for greater awareness and a differentiated approach to patients at increased risk of anxiety and depression in the early stages of treatment and before starting chemotherapy.

Original languageEnglish
Pages (from-to)562-570
Number of pages9
JournalPsychology Health & Medicine
Volume21
Issue number5
DOIs
Publication statusPublished - Jul 2016

Fingerprint

Anxiety
Cross-Sectional Studies
Depression
Neoplasms
Demography
Thermometers
Drug Therapy
Pain Measurement
Psychiatry
Breast
Referral and Consultation
Lung

Keywords

  • Anxiety
  • cancer
  • depression
  • distress
  • risk factors

Cite this

@article{4b4db0518c3e49e9a237c832854ec221,
title = "Depression and anxiety symptoms following cancer diagnosis: a cross-sectional study",
abstract = "Introduction: The aims of the present study were to assess demographic and clinical characteristics of patients after receiving a cancer diagnosis, and to determine possible risk factors for anxiety and depression. Methods: All consecutive patients aged 18 or above, were assessed before starting intravenous chemotherapy for the first time with the Hospital Anxiety and Depression Scale (HADS), the Distress Thermometer, and a Visual Analog Scale for pain. Demographic and clinical data were also collected. Results: The patients assessed (n = 270) had a mean age of 59.4 (SD = 11.8) years, and 50.7{\%} were women. Tumours were more frequently colorectal (27.2{\%}), lung (18.8{\%}) and breast (17.6{\%}), and 68.9{\%} were stages 3 or 4. A HADS Anxiety score ≥8 was present in 30{\%} of the patients, a Depression score ≥8 in 24.1{\%}, and a Distress score ≥4 in 44.4{\%}. Independent risk factors for HADS Depression score ≥8 were being a woman (OR = 2.45; p = 0.004), being older (OR = 1.04; p = 0.005), and cancer stage 3–4 (OR = 2.24; p = 0.023) in the multivariable analysis; for Anxiety ≥8 they were being a woman (OR = 2.47; p = 0.002), having a past psychiatric consultation (OR = 2.83; p = 0.029), and cancer stage 3–4 (OR = 1.90; p = 0.047). Conclusion: These results suggest the need for greater awareness and a differentiated approach to patients at increased risk of anxiety and depression in the early stages of treatment and before starting chemotherapy.",
keywords = "Anxiety, cancer, depression, distress, risk factors",
author = "Gra{\cc}a Cardoso and Joao Graca and Catarina Klut and Bruno Trancas and Ana Papoila",
year = "2016",
month = "7",
doi = "10.1080/13548506.2015.1125006",
language = "English",
volume = "21",
pages = "562--570",
journal = "Psychology Health & Medicine",
issn = "1354-8506",
publisher = "Taylor & Francis",
number = "5",

}

Depression and anxiety symptoms following cancer diagnosis : a cross-sectional study. / Cardoso, Graça; Graca, Joao; Klut, Catarina; Trancas, Bruno; Papoila, Ana.

In: Psychology Health & Medicine, Vol. 21, No. 5, 07.2016, p. 562-570.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Depression and anxiety symptoms following cancer diagnosis

T2 - a cross-sectional study

AU - Cardoso, Graça

AU - Graca, Joao

AU - Klut, Catarina

AU - Trancas, Bruno

AU - Papoila, Ana

PY - 2016/7

Y1 - 2016/7

N2 - Introduction: The aims of the present study were to assess demographic and clinical characteristics of patients after receiving a cancer diagnosis, and to determine possible risk factors for anxiety and depression. Methods: All consecutive patients aged 18 or above, were assessed before starting intravenous chemotherapy for the first time with the Hospital Anxiety and Depression Scale (HADS), the Distress Thermometer, and a Visual Analog Scale for pain. Demographic and clinical data were also collected. Results: The patients assessed (n = 270) had a mean age of 59.4 (SD = 11.8) years, and 50.7% were women. Tumours were more frequently colorectal (27.2%), lung (18.8%) and breast (17.6%), and 68.9% were stages 3 or 4. A HADS Anxiety score ≥8 was present in 30% of the patients, a Depression score ≥8 in 24.1%, and a Distress score ≥4 in 44.4%. Independent risk factors for HADS Depression score ≥8 were being a woman (OR = 2.45; p = 0.004), being older (OR = 1.04; p = 0.005), and cancer stage 3–4 (OR = 2.24; p = 0.023) in the multivariable analysis; for Anxiety ≥8 they were being a woman (OR = 2.47; p = 0.002), having a past psychiatric consultation (OR = 2.83; p = 0.029), and cancer stage 3–4 (OR = 1.90; p = 0.047). Conclusion: These results suggest the need for greater awareness and a differentiated approach to patients at increased risk of anxiety and depression in the early stages of treatment and before starting chemotherapy.

AB - Introduction: The aims of the present study were to assess demographic and clinical characteristics of patients after receiving a cancer diagnosis, and to determine possible risk factors for anxiety and depression. Methods: All consecutive patients aged 18 or above, were assessed before starting intravenous chemotherapy for the first time with the Hospital Anxiety and Depression Scale (HADS), the Distress Thermometer, and a Visual Analog Scale for pain. Demographic and clinical data were also collected. Results: The patients assessed (n = 270) had a mean age of 59.4 (SD = 11.8) years, and 50.7% were women. Tumours were more frequently colorectal (27.2%), lung (18.8%) and breast (17.6%), and 68.9% were stages 3 or 4. A HADS Anxiety score ≥8 was present in 30% of the patients, a Depression score ≥8 in 24.1%, and a Distress score ≥4 in 44.4%. Independent risk factors for HADS Depression score ≥8 were being a woman (OR = 2.45; p = 0.004), being older (OR = 1.04; p = 0.005), and cancer stage 3–4 (OR = 2.24; p = 0.023) in the multivariable analysis; for Anxiety ≥8 they were being a woman (OR = 2.47; p = 0.002), having a past psychiatric consultation (OR = 2.83; p = 0.029), and cancer stage 3–4 (OR = 1.90; p = 0.047). Conclusion: These results suggest the need for greater awareness and a differentiated approach to patients at increased risk of anxiety and depression in the early stages of treatment and before starting chemotherapy.

KW - Anxiety

KW - cancer

KW - depression

KW - distress

KW - risk factors

UR - http://www.scopus.com/inward/record.url?scp=84950154786&partnerID=8YFLogxK

U2 - 10.1080/13548506.2015.1125006

DO - 10.1080/13548506.2015.1125006

M3 - Article

VL - 21

SP - 562

EP - 570

JO - Psychology Health & Medicine

JF - Psychology Health & Medicine

SN - 1354-8506

IS - 5

ER -